J B Soriano

Summary

Country: Spain

Publications

  1. ncbi High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease
    Joan B Soriano
    Fundació Caubet CIMERA Illes Balears, CIMERA, Bunyola, Spain
    Chest 137:333-40. 2010
  2. ncbi Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification
    Joan B Soriano
    Fundación Caubet Cimera Centro Internacional de Medicina Respiratoria Avanzada, Bunyola, Spain
    Chest 143:694-702. 2013
  3. ncbi The general public's knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes
    Joan B Soriano
    Programa de Epidemiología e Investigación Clínica Fundación Caubet CIMERA Illes Balears, Bunyola, Islas Baleares, Espana
    Arch Bronconeumol 48:308-15. 2012
  4. ncbi Chronic obstructive pulmonary disease: a worldwide problem
    Joan B Soriano
    Fundació Caubet CIMERA Illes Balears, Recinte Hospital Joan March, Mallorca, Illes Balears, Spain
    Med Clin North Am 96:671-80. 2012
  5. ncbi Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants
    Joan B Soriano
    Fundació Caubet CIMERA, Bunyola, Spain
    Prim Care Respir J 21:187-93. 2012
  6. ncbi Identification and diversity of multiresistant Corynebacterium striatum clinical isolates by MALDI-TOF mass spectrometry and by a multigene sequencing approach
    Margarita Gomila
    Unidad de Investigación Microbiología, Fundación Hospital Son Llàtzer, Ctra, Manacor, km, 4, 07198 Palma de Mallorca, Illes Balears, Spain
    BMC Microbiol 12:52. 2012
  7. ncbi Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
    Francisco Garcia-Rio
    Pneumology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
    Respir Res 11:63. 2010
  8. ncbi Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation
    Joan B Soriano
    Fundacio n Caubet CIMERA Illes Balears, Bunyola, Spain
    Proc Am Thorac Soc 8:363-7. 2011
  9. ncbi [Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]
    Joan B Soriano
    Fundación Caubet CIMERA, Illes Balears, Espana
    Arch Bronconeumol 46:522-30. 2010
  10. ncbi Set-up and pilot of a population cohort for the study of the natural history of COPD and OSA: the PULSAIB study
    Joan B Soriano
    Program of Epidemiology and Clinical Research, CIMERA, Fundación Caubet CIMERA Illes Balears, Bunyola, Mallorca, Spain
    Prim Care Respir J 19:140-7. 2010

Collaborators

Detail Information

Publications19

  1. ncbi High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease
    Joan B Soriano
    Fundació Caubet CIMERA Illes Balears, CIMERA, Bunyola, Spain
    Chest 137:333-40. 2010
    ..The prevalence of airflow limitation (AL) in patients with cardiovascular disease (CVD) is unknown, and whether AL is adequately diagnosed and treated in these patients has not been investigated before, to our knowledge...
  2. ncbi Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification
    Joan B Soriano
    Fundación Caubet Cimera Centro Internacional de Medicina Respiratoria Avanzada, Bunyola, Spain
    Chest 143:694-702. 2013
    ..We aimed to determine their distribution in 11 well-defined COPD cohorts and their prognostic validity up to 10 years to predict time to death...
  3. ncbi The general public's knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes
    Joan B Soriano
    Programa de Epidemiología e Investigación Clínica Fundación Caubet CIMERA Illes Balears, Bunyola, Islas Baleares, Espana
    Arch Bronconeumol 48:308-15. 2012
    ..The objective of this study was to determine the level of knowledge about chronic obstructive pulmonary disease (COPD) and its determinants in the general population of Spain, and to compare it with a similar survey conducted in 2002...
  4. ncbi Chronic obstructive pulmonary disease: a worldwide problem
    Joan B Soriano
    Fundació Caubet CIMERA Illes Balears, Recinte Hospital Joan March, Mallorca, Illes Balears, Spain
    Med Clin North Am 96:671-80. 2012
    ..This review summarizes the magnitude of the COPD problem at the population and individual levels...
  5. ncbi Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants
    Joan B Soriano
    Fundació Caubet CIMERA, Bunyola, Spain
    Prim Care Respir J 21:187-93. 2012
    ..A spirometrically-defined restrictive ventilatory defect is a common finding when performing spirometry...
  6. ncbi Identification and diversity of multiresistant Corynebacterium striatum clinical isolates by MALDI-TOF mass spectrometry and by a multigene sequencing approach
    Margarita Gomila
    Unidad de Investigación Microbiología, Fundación Hospital Son Llàtzer, Ctra, Manacor, km, 4, 07198 Palma de Mallorca, Illes Balears, Spain
    BMC Microbiol 12:52. 2012
    ..Strains were also characterised phenotypically by their antibiotic resistance profiles and by MALDI-TOF mass spectrometry analysis...
  7. ncbi Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
    Francisco Garcia-Rio
    Pneumology Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
    Respir Res 11:63. 2010
    ..The aims of this study were to compare the levels of several systemic biomarkers between stable COPD patients and healthy subjects from a population-based sample, and to assess their distribution according to clinical variables...
  8. ncbi Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation
    Joan B Soriano
    Fundacio n Caubet CIMERA Illes Balears, Bunyola, Spain
    Proc Am Thorac Soc 8:363-7. 2011
    ..Hopefully, the COPD clinical course will shift to better outcomes and prognosis than in the past...
  9. ncbi [Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]
    Joan B Soriano
    Fundación Caubet CIMERA, Illes Balears, Espana
    Arch Bronconeumol 46:522-30. 2010
    ..2% of the 40 to 80 years population. Little is known about the current geographical variation of COPD in Spain...
  10. ncbi Set-up and pilot of a population cohort for the study of the natural history of COPD and OSA: the PULSAIB study
    Joan B Soriano
    Program of Epidemiology and Clinical Research, CIMERA, Fundación Caubet CIMERA Illes Balears, Bunyola, Mallorca, Spain
    Prim Care Respir J 19:140-7. 2010
    ....
  11. ncbi [Causes of mortality in COPD]
    Joan B Soriano Ortiz
    Programa de Epidemiología e Investigación Clínica, Fundación Caubet CIMERA, Illes Balears, Espana
    Arch Bronconeumol 45:8-13. 2009
    ..Fortunately, in the latest updates, guidelines for the management and treatment of the disease identify reduction of mortality as one of the main clinical objectives to be achieved in these patients...
  12. ncbi Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007
    J B Soriano
    Fundació Caubet CIMERA, Illes Balears, Mallorca, Spain
    Eur Respir J 36:758-65. 2010
    ....
  13. ncbi Screening for and early detection of chronic obstructive pulmonary disease
    Joan B Soriano
    CIMERA International Center for Advanced Respiratory Medicine, Recinte Hospital Joan March, Bunyola, Spain
    Lancet 374:721-32. 2009
    ..All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD...
  14. ncbi A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo
    Joan B Soriano
    Head, Program of Epidemiology and Clinical Research, Fundació Caubet CIMERA Illes Balears, International Centre for Advanced Respiratory Medicine, Recinte Hospital Joan March, Bunyola, Mallorca, Spain
    Chest 131:682-9. 2007
    ..There is controversy about whether therapy with inhaled corticosteroids (ICSs) modifies the natural history of COPD, characterized by an accelerated decline in FEV(1)...
  15. ncbi Effectiveness of pulmonary rehabilitation in reducing health resources use in chronic obstructive pulmonary disease
    Mateu Rubí
    Respiratory Unit, Hospital Joan March, Bunyola, Spain
    Arch Phys Med Rehabil 91:364-8. 2010
    ..PR is recommended in advanced COPD, but there is limited evidence on the effectiveness of PR in reducing health care resources when applied in outpatients...
  16. ncbi The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort
    Robab Kohansal
    Epidemiology and Clinical Research, Fundación Caubet CIMERA Illes Balears, Recinte Hospital Joan March, 07110 Bunyola, Illes Balears, Spain
    Am J Respir Crit Care Med 180:3-10. 2009
    ..Understanding normal lung development and aging in health and disease, both in men and in women, is essential to interpreting any therapeutic intervention...
  17. ncbi Investigating the natural history of lung function: facts, pitfalls, and opportunities
    Robab Kohansal
    Program of Epidemiology and Clinical Research, Fundación Caubet CIMERA Illes Balears, Recinte Hospital Joan March, Illes Balears, Spain
    Chest 135:1330-41. 2009
    ..Finally, some characteristics of an "ideal" study on the natural history of lung function decline are recommended, both in health and disease...
  18. ncbi Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease
    Feliu Renom
    Respiratory Unit, Hospital Joan March, Carretera Palma Sóller, Bunyola, Illes Balears, Spain
    J Clin Microbiol 45:2064-7. 2007
    ..C. striatum is a potentially pathogenic microorganism with the ability to produce nosocomial infectious outbreaks and respiratory colonization in patients with advanced COPD...
  19. ncbi COPD as a systemic disease
    Alvar Agusti
    Fundación Caubet CIMERA Illes Balears, Mallorca, Spain
    COPD 5:133-8. 2008
    ....